CH626373A5 - - Google Patents

Download PDF

Info

Publication number
CH626373A5
CH626373A5 CH218277A CH218277A CH626373A5 CH 626373 A5 CH626373 A5 CH 626373A5 CH 218277 A CH218277 A CH 218277A CH 218277 A CH218277 A CH 218277A CH 626373 A5 CH626373 A5 CH 626373A5
Authority
CH
Switzerland
Prior art keywords
formula
butyl
hydroxy
sec
choh
Prior art date
Application number
CH218277A
Other languages
German (de)
English (en)
Inventor
Gerard Maurer
Jean-Rene Dr Kiechel
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to CH218277A priority Critical patent/CH626373A5/de
Priority to DE19782805977 priority patent/DE2805977A1/de
Priority to NL7801815A priority patent/NL7801815A/xx
Priority to BE185311A priority patent/BE864126A/xx
Priority to GB6594/78A priority patent/GB1598022A/en
Priority to FR7804826A priority patent/FR2381055A1/fr
Priority to IT48125/78A priority patent/IT1104170B/it
Priority to JP1818278A priority patent/JPS53103499A/ja
Priority to US06/119,877 priority patent/US4251529A/en
Publication of CH626373A5 publication Critical patent/CH626373A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CH218277A 1977-02-22 1977-02-22 CH626373A5 (fi)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CH218277A CH626373A5 (fi) 1977-02-22 1977-02-22
DE19782805977 DE2805977A1 (de) 1977-02-22 1978-02-13 Neue ergopeptidalkaloide, ihre herstellung und verwendung
NL7801815A NL7801815A (nl) 1977-02-22 1978-02-17 Ergotpeptidealkaloiden en werkwijzen voor het bereiden en toepassen van deze alkaloiden.
BE185311A BE864126A (fr) 1977-02-22 1978-02-20 Nouveaux derives d'alcaloides peptidiques de l'ergot de seigle, leur preparation et leur application comme medicaments
GB6594/78A GB1598022A (en) 1977-02-22 1978-02-20 9,10-dihydroergocryptines and some open chain derivatives thereof
FR7804826A FR2381055A1 (fr) 1977-02-22 1978-02-21 Nouveaux derives d'alcaloides peptidiques de l'ergot de seigle, leur preparation et leur application comme medicaments
IT48125/78A IT1104170B (it) 1977-02-22 1978-02-21 Derivati d'alcoloidi peptidici della segale cornuta loro preparazione e loro impiego quali medicamenti
JP1818278A JPS53103499A (en) 1977-02-22 1978-02-21 Improvement in organic compound
US06/119,877 US4251529A (en) 1977-02-22 1980-02-08 Ergot peptide alkaloids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH218277A CH626373A5 (fi) 1977-02-22 1977-02-22

Publications (1)

Publication Number Publication Date
CH626373A5 true CH626373A5 (fi) 1981-11-13

Family

ID=4227800

Family Applications (1)

Application Number Title Priority Date Filing Date
CH218277A CH626373A5 (fi) 1977-02-22 1977-02-22

Country Status (9)

Country Link
US (1) US4251529A (fi)
JP (1) JPS53103499A (fi)
BE (1) BE864126A (fi)
CH (1) CH626373A5 (fi)
DE (1) DE2805977A1 (fi)
FR (1) FR2381055A1 (fi)
GB (1) GB1598022A (fi)
IT (1) IT1104170B (fi)
NL (1) NL7801815A (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH646707A5 (en) * 1980-03-03 1984-12-14 Richter Gedeon Vegyeszet Process for the preparation of ergot alkaloids
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
US5069911A (en) * 1985-02-05 1991-12-03 Sandoz Ltd. Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions

Also Published As

Publication number Publication date
FR2381055B1 (fi) 1980-08-29
JPS53103499A (en) 1978-09-08
GB1598022A (en) 1981-09-16
NL7801815A (nl) 1978-08-24
IT1104170B (it) 1985-10-21
JPS6118556B2 (fi) 1986-05-13
US4251529A (en) 1981-02-17
IT7848125A0 (it) 1978-02-21
BE864126A (fr) 1978-08-21
DE2805977A1 (de) 1978-08-31
FR2381055A1 (fr) 1978-09-15

Similar Documents

Publication Publication Date Title
DE3001328C2 (fi)
DE2606265A1 (de) Camptothecin-derivate
DD203052A5 (de) Verfahren zur herstellung von 9-(1,3-dihydroxy-2-propoxy-methyl)-guanin, dessen salzen und bestimmten benzylderivaten desselben
WO1994018199A1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
DE2415980A1 (de) Neue aminderivate von vinblastin, leurosidin und leurocristin und verfahren zu ihrer herstellung
DE2736784A1 (de) N-substituierte und nichtsubstituierte hexahydro-6-canthinonderivate, verfahren zum herstellen derselben und diese derivate enthaltende pharmazeutische zusammensetzung
AT392279B (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
EP0001115A2 (de) 2-Bromergosin und seine Säureadditionssalze, Verfahren zu deren Herstellung sowie deren Verwendung als Heilmittel
CH651563A5 (de) Hydroxyimino-oktahydro-indolo(2,3-a)chinolizin-derivate sowie verfahren zu ihrer herstellung.
DE3789290T2 (de) Theophyllinmethyldithiolan und Theophyllinmethyldithianylderivate, ein Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate.
DE2504045B2 (de) 16,17 dihydro-apovincaminsaeure-2- hydroxypropylester, deren salze, verfahren zu ihrer herstellung und arzneimittel
CH626373A5 (fi)
DE3721223C2 (fi)
CH666036A5 (de) In 6-stellung substituierte mitomycin-analoge.
DE3226921C2 (de) Neue 3,7-Diazabicyclo[3.3.1]nonan Verbindungen und Verfahren zu ihrer Herstellung
DE3120910C2 (fi)
EP0290003A2 (de) Neue Imidazole
EP0180833B1 (de) 4-Oxo-pyrido[2,3]pyrimidin-Derivate, Verfahren zur deren Herstellung und diese ethaltende Arzneimittel
DE2716172C2 (de) Bis(6-[(hexahydro-1H-azepin-1-yl)-methylenamino]-penicillanoyloxy)-methan, seine Herstellung und dieses enthaltendes Arzneimittel
CH634849A5 (de) In 3'-stellung oxygenierte derivate von 4'-desoxy-vincaleukoblastin ''a'' und ''b'' sowie verwandte 1-formylverbindungen.
EP0003286B1 (de) Ergopeptidalkaloid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69729890T2 (de) Heilmittel/vorbeugemittel für erkrankungen der atemwege
DE2410201B2 (de) 6-substituierte 3-carbaethoxyhydrazinopyridazine beziehungsweise ihre salze sowie solche enthaltende arzneimittel und verfahren zur herstellung derselben
DE3703633A1 (de) Purin-derivate, ihre herstellung und sie enthaltende arzneimittel
DE1941933C3 (de) Basisch substituierte 10,11- Dihydro-5,10-endoxa-SH-dibenzo- [a,d] -cycloheptene und deren pharmakologisch verträgliche Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Legal Events

Date Code Title Description
PL Patent ceased